Chonluten 20 mg

Chonluten is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a synthetic tripeptide with the sequence Glu-Asp-Gly (EDG), Chonluten was developed to investigate how minimal peptide sequences interact with bronchial epithelial tissue and pulmonary mucosal research models. Its compact structure positions Chonluten as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Chonluten is studied for its proposed ability to engage with chromatin structure and modulate transcriptional activity within bronchial epithelial cells and respiratory mucosal cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with epithelial renewal, mucosal-barrier maintenance, and cytokine-related signaling in airway-derived cell systems. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Chonluten centers on lung-tissue gene expression studies, bronchial epithelial renewal research models, and mucosal regulation investigations. Comparative work on tissue-specific bioregulators positions Chonluten alongside other respiratory-targeted oligopeptides used to explore peptidergic regulation of pulmonary biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the EDG sequence influences epithelial gene-expression profiles in bronchial research models, supporting continued laboratory investigation of Chonluten in pulmonary and mucosal biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The development of short peptide bioregulators began in the 1970s at the Military Medical Academy in Saint Petersburg, where Professor Vladimir Khavinson and colleagues isolated peptide fractions from animal tissues that appeared to restore organ-specific function in experimental models. This work led to the founding of the Saint Petersburg Institute of Bioregulation and Gerontology and the systematic study of tissue-derived peptide complexes, including the bronchial-epithelial peptide complex from which Chonluten was later derived.

Chonluten was identified within this research program as a synthetic tripeptide bioregulator with the sequence Glu-Asp-Gly (EDG), associated with bronchial epithelial tissue and pulmonary mucosal research models. Subsequent biochemical and molecular investigations explored how this peptide interacts with chromatin and influences epithelial gene expression, supporting the hypothesis that minimal peptide sequences can act as tissue-specific gene-expression modulators within airway and mucosal cell systems.

Today, Chonluten is positioned within the wider family of Khavinson-school oligopeptides studied for lung-tissue gene expression, bronchial epithelial renewal research, and mucosal regulation research in laboratory contexts.

1. Chromatin Interaction and Bronchial Gene Expression

Within the Khavinson framework, Chonluten is proposed to interact with specific regions of double-stranded DNA and associated chromatin proteins, where it has been reported to influence gene-expression patterns in bronchial epithelial research models. This proposed mode of action positions Chonluten as a tool for investigating peptide-mediated chromatin engagement and transcriptional regulation in airway-derived cell systems.

2. Bronchial Epithelial Signaling and Mucosal Pathways

Research observations suggest that Chonluten engages with intracellular signaling pathways relevant to bronchial epithelial function, including pathways associated with epithelial renewal research and mucosal-barrier maintenance research models. These observations make Chonluten a useful compound for exploring tissue-specific peptide signaling in pulmonary cell-culture systems.

3. Cytokine-Associated Signaling Research

Comparative work on short peptide bioregulators indicates that the EDG sequence is associated with cytokine-related signaling changes in epithelial cell models, including studies involving TNF-alpha and interleukin-6 research pathways. In airway research models, Chonluten is investigated for its role in inflammatory-signaling research, epithelial cytokine balance studies, and immune-epithelial interaction investigations.

4. Adaptive and Homeostatic Signaling

Khavinson-school bioregulators are described as adaptive peptide regulators that operate under physiological stress conditions. Chonluten is studied for its proposed contribution to bronchial-tissue homeostasis research, including models of age-related decline in epithelial-cell signaling and oxidative stress adaptation in mucosal cell systems.

Research Applications

Conclusion

Chonluten is a Khavinson-school short peptide bioregulator with the sequence Glu-Asp-Gly, studied for its proposed role in lung-tissue gene expression, bronchial epithelial renewal research, and mucosal regulation research. Its compact tripeptide structure and respiratory-tissue positioning make Chonluten a valuable laboratory compound for exploring peptidergic regulation of gene expression in pulmonary research models.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.